> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Seeks End to Dog Use in Clinical Trials
- URL: https://www.fdaweb.com/fda-seeks-end-to-dog-use-in-clinical-trials/
- Published: 2018-11-16T12:00:00.000Z
- Updated: 2026-09-15T00:45:11.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142842

FDA is seeking to eliminate the use of dogs in clinical research by animal drug developers. The [agency says](https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626060.htm?ref=fdaweb.com) it will propose a study that, once completed, could help establish a non-animal based model that will “potentially replace much of the need to use dogs in future trials with new informatics tools. In short, our goal is to do one single study involving a small number of dogs — where the dogs will only be subject to minimally invasive blood sampling, and adopted as pets at the completion of the short trial — to eliminate the need for the use of dogs in certain types of future studies, some where they might have been euthanized.”

The proposed study is part of FDA’s recent efforts to reduce reliance on animals used in research. The study goal is to validate a research model for comparing blood levels of certain orally-administered canine drugs in order to provide an alternative approach that animal drug developers can use to generate data to support FDA product approval. The agency is accepting [public comment](https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm625772.htm?ref=fdaweb.com) on a [white paper](https://www.fda.gov/downloads/AnimalVeterinary/ScienceResearch/ToolsResources/UCM626050.pdf?ref=fdaweb.com) outlining this proposed study for the next 60 days.